OSAHS患者相关炎症指标研究进展

祁 雪芳
青海大学附属医院

摘要


阻塞性睡眠呼吸暂停低通气综合征（obstructive sleep apnea hypopnea syndrom，OSAHS）是一种非常普遍的
睡眠相关呼吸障碍，其特征是通气不足和通气呼吸暂停，在睡眠期间气道变窄或塌陷，导致阻塞性睡眠呼吸暂停。
目前一些研究表明炎症在OSAHS的发生与发展中起着至关重要的作用，OSAHS诱导的局部或全身炎症可能引起血
管内皮功能障碍，从而导致各种并发症，如心血管疾病、代谢功能障碍，目前对于OSAHS与血清炎症指标的相关性
研究仍处于起步阶段，本文旨在综述炎症指标与OSAHS严重程度相关性研究进展，对于早期识别该病相关并发症提
供一定的参考价值。

关键词


炎症指标；阻塞性睡眠呼吸暂停低通气综合征；心血管疾病

全文:

PDF


参考


[1]Lv R, Liu X, Zhang Y, et al. Pathophysiological

mechanisms and therapeutic approaches in obstructive

sleep apnea syndrome[J]. Signal Transduction and Targeted

Therapy, 2023, 8: 218.

[2]Kapur VK, Auckley DH, Chowdhuri S, et al.

Clinical Practice Guideline for Diagnostic Testing for Adult

Obstructive Sleep Apnea: An American Academy of Sleep

Medicine Clinical Practice Guideline[J]. Journal of Clinical

Sleep Medicine : JCSM : Official Publication of the American

Academy of Sleep Medicine, 2017, 13(3): 479-504.

[3]Chen YC, Hsu PY, Hsiao CC, et al. Epigenetics:

A Potential Mechanism Involved in the Pathogenesis of

Various Adverse Consequences of Obstructive Sleep Apnea[J].

International Journal of Molecular Sciences, 2019, 20(12): 2937.

[4]Maniaci A, Iannella G, Cocuzza S, et al. Oxidative

Stress and Inflammation Biomarker Expression in Obstructive

Sleep Apnea Patients[J]. Journal of Clinical Medicine, 2021,

10(2): 277.

[5]Liu X, Ma Y, Ouyang R, et al. The relationship

between inflammation and neurocognitive dysfunction

in obstructive sleep apnea syndrome[J]. Journal of

Neuroinflammation, 2020, 17: 229.

[6]Ryan S, Taylor CT, McNicholas WT. Selective

activation of inflammatory pathways by intermittent hypoxia

in obstructive sleep apnea syndrome[J]. Circulation, 2005,

112(17): 2660-2667.

[7]Medeiros AKL, Coutinho RQ, Barros IML, et al.

Obstructive sleep apnea is independently associated with

subclinical coronary atherosclerosis among middle-aged

women[J]. Sleep & Breathing = Schlaf & Atmung, 2017,

21(1): 77-83.

[8]Drager LF, Bortolotto LA, Maki-Nunes C, et al.

The incremental role of obstructive sleep apnoea on markers

of atherosclerosis in patients with metabolic syndrome[J].

Atherosclerosis, 2010, 208(2): 490-495.

[9]Brockhaus M, Schoenfeld HJ, Schlaeger EJ, et al.

Identification of two types of tumor necrosis factor receptors

on human cell lines by monoclonal antibodies.[J]. Proceedings

of the National Academy of Sciences of the United States of

America, 1990, 87(8): 3127-3131.

[10]Nadeem R, Molnar J, Madbouly EM, et al. Serum

inflammatory markers in obstructive sleep apnea: a meta-

analysis[J]. Journal of clinical sleep medicine: JCSM: official

publication of the American Academy of Sleep Medicine,

2013, 9(10): 1003-1012.

[11]Ming H, Tian A, Liu B, et al. Inflammatory

cytokines tumor necrosis factor-α, interleukin-8 and

sleep monitoring in patients with obstructive sleep apnea

syndrome[J]. Experimental and Therapeutic Medicine, 2019,

17(3): 1766-1770.

[12]Krueger JM, Opp MR. Sleep and Microbes[J].

International review of neurobiology, 2016, 131: 207-225.

[13]Rockstrom M, Chen L, Taishi P, et al. Tumor

Necrosis Factor Alpha in Sleep Regulation[J]. Sleep medicine

reviews, 2018, 40: 69-78.

[14]Campos-Rodriguez F, Asensio-Cruz MI, CorderoGuevara J, et al. Effect of continuous positive airway pressure

on inflammatory, antioxidant, and depression biomarkers in

women with obstructive sleep apnea: a randomized controlled

trial[J]. Sleep, 2019, 42(10): zsz145.

[15]Chen CY, Chen CL, Yu CC, et al. Association of

inflammation and oxidative stress with obstructive sleep apnea

in ischemic stroke patients[J]. Sleep Medicine, 2015, 16(1):

113-118.

[16]Testelmans D, Tamisier R, Barone-Rochette G,

et al. Profile of circulating cytokines: impact of OSA, obesity

and acute cardiovascular events[J]. Cytokine, 2013, 62(2):

210-216.

[17]Li K, Wei P, Qin Y, et al. Is C-reactive protein a

marker of obstructive sleep apnea?[J]. Medicine, 2017, 96(19):

e6850.

[18]Castell JV, Gómez-Lechón MJ, David M, et al.

Acute-phase response of human hepatocytes: regulation of

acute-phase protein synthesis by interleukin-6[J]. Hepatology

(Baltimore, Md.), 1990, 12(5): 1179-1186.

[19]Yokoe T, Minoguchi K, Matsuo H, et al. Elevated

levels of C-reactive protein and interleukin-6 in patients

with obstructive sleep apnea syndrome are decreased by nasal

continuous positive airway pressure[J]. Circulation, 2003,

107(8): 1129-1134.

[20]Guven SF, Turkkani MH, Ciftci B, et al. The

relationship between high-sensitivity C-reactive protein

levels and the severity of obstructive sleep apnea[J]. Sleep &

Breathing = Schlaf & Atmung, 2012, 16(1): 217-221.

[21]Sharma SK, Mishra HK, Sharma H, et al. Obesity,

and not obstructive sleep apnea, is responsible for increased

serum hs-CRP levels in patients with sleep-disordered

breathing in Delhi[J]. Sleep Medicine, 2008, 9(2): 149-156.

[22]Bouloukaki I, Mermigkis C, Kallergis EM, et al.

Obstructive sleep apnea syndrome and cardiovascular disease:

The influence of C-reactive protein[J]. World Journal of

Experimental Medicine, 2015, 5(2): 77-83.

[23]Yudkin JS, Kumari M, Humphries SE, et al.

Inflammation, obesity, stress and coronary heart disease: is

interleukin-6 the link?[J]. Atherosclerosis, 2000, 148(2): 209-

214.

[24]Heinrich PC, Castell JV, Andus T. Interleukin-6

and the acute phase response.[J]. Biochemical Journal, 1990,

265(3): 621-636.

[25]Mohamed-Ali V, Goodrick S, Rawesh A, et al.

Subcutaneous adipose tissue releases interleukin-6, but not

tumor necrosis factor-alpha, in vivo[J]. The Journal of Clinical

Endocrinology and Metabolism, 1997, 82(12): 4196-4200.

[26]Ueda K, Takahashi M, Ozawa K, et al. Decreased

soluble interleukin-6 receptor in patients with acute

myocardial infarction[J]. American Heart Journal, 1999,

138(5): 908-915.

[27]Chuang LP, Wu HP, Lee LA, et al. Elevated

Monocytic Interleukin-8 Expression under Intermittent

Hypoxia Condition and in Obstructive Sleep Apnea

Patients[J]. International Journal of Molecular Sciences, 2021,

22(21): 11396.

[28]Malkov MI, Lee CT, Taylor CT. Regulation of

the Hypoxia-Inducible Factor (HIF) by Pro-Inflammatory

Cytokines[J]. Cells, 2021, 10(9): 2340.

[29]Sahlman J, Miettinen K, Peuhkurinen K, et al.

The activation of the inflammatory cytokines in overweight

patients with mild obstructive sleep apnoea[J]. Journal of Sleep

Research, 2010, 19(2): 341-348.

[30]Ciftci TU, Kokturk O, Bukan N, et al. The

relationship between serum cytokine levels with obesity and

obstructive sleep apnea syndrome[J]. Cytokine, 2004, 28(2):

87-91.

[31]Lindmark E, Diderholm E, Wallentin L, et al.

Relationship between interleukin 6 and mortality in patients

with unstable coronary artery disease: effects of an early

invasive or noninvasive strategy[J]. JAMA, 2001, 286(17):

2107-2113.

[32]JIANG WG, SANDERS AJ, RUGE F, et al.

Influence of interleukin-8 (IL-8) and IL-8 receptors on

the migration of human keratinocytes, the role of PLC-γ

and potential clinical implications[J]. Experimental and

Therapeutic Medicine, 2012, 3(2): 231-236.

[33]Akyol S, Çörtük M, Baykan AO, et al. Mean

platelet volume is associated with disease severity in patients

with obstructive sleep apnea syndrome[J]. Clinics, 2015, 70(7):

481-485.

[34]Azagra-Calero E, Espinar-Escalona E, BarreraMora JM, et al. Obstructive Sleep Apnea Syndrome (OSAS).

Review of the literature[J]. Medicina Oral, Patología Oral y

Cirugía Bucal, 2012, 17(6): e925-e929.

[35]Li X, Hu R, Ren X, et al. Interleukin-8

concentrations in obstructive sleep apnea syndrome: a

systematic review and meta-analysis[J]. Bioengineered, [2024],

12(2): 10650-10665.

[36]Wang Z, Zeng Y, Lin H. The effect of chronic

intermittent hypoxia on atherosclerosis in rat offspring[J].

International Journal of Cardiology, 2021, 335: 98-103.

[37]Vagdatli E, Gounari E, Lazaridou E, et al. Platelet

distribution width: a simple, practical and specific marker of

activation of coagulation[J]. Hippokratia, 2010, 14(1): 28-32.

[38]Rahangdale S, Yeh SY, Novack V, et al. The

Influence of Intermittent Hypoxemia on Platelet Activation

in Obese Patients with Obstructive Sleep Apnea[J]. Journal of

Clinical Sleep Medicine : JCSM : Official Publication of the

American Academy of Sleep Medicine, 2011, 7(2): 172-178.

[39]Anfossi G, Trovati M. Role of catecholamines

in platelet function: pathophysiological and clinical

significance[J]. European Journal of Clinical Investigation,

1996, 26(5): 353-370.

[40]Ma Q, Zhu C, Zhang W, et al. Mitochondrial

PIP3-binding protein FUNDC2 supports platelet survival via

AKT signaling pathway[J]. Cell Death and Differentiation,

2019, 26(2): 321-331.

[41]Di Lorenzo B, Scala C, Mangoni AA, et al. A

Systematic Review and Meta-Analysis of Mean Platelet

Volume and Platelet Distribution Width in Patients with

Obstructive Sleep Apnoea Syndrome[J]. Biomedicines, 2024,

12(2): 270.

[42]Zeng J, He J, Chen M, et al. Association between

mean platelet volume and obstructive sleep apnea-hypopnea

syndrome: A systemic review and meta-analysis[J]. PLOS

ONE, 2024, 19(2): e0297815.

[43]Azab B, Bhatt VR, Phookan J, et al. Usefulness of

the neutrophil-to-lymphocyte ratio in predicting short- and

long-term mortality in breast cancer patients[J]. Annals of

Surgical Oncology, 2012, 19(1): 217-224.

[44]Azab B, Zaher M, Weiserbs KF, et al. Usefulness

of neutrophil to lymphocyte ratio in predicting short- and

long-term mortality after non-ST-elevation myocardial

infarction[J]. The American Journal of Cardiology, 2010,

106(4): 470-476.

[45]Rha MS, Kim CH, Yoon JH, et al. Association

between the neutrophil-to-lymphocyte ratio and obstructive

sleep apnea: a meta-analysis[J]. Scientific Reports, 2020, 10:

10862.

[46]Balta S, Demırkol S, Kucuk U. The platelet

lymphocyte ratio may be useful inflammatory indicator in

clinical practice[J]. Hemodialysis International. International

Symposium on Home Hemodialysis, 2013, 17(4): 668-669.

[47]Yu B, Wei J, Zhao J, et al. The neutrophil-tolymphocyte ratio is a potential biomarker for the occurrence

of atrial fibrillation in patients with obstructive sleep apnea:

A BIOMARKER OF AF IN OSA PATIENTS[J]. Sleep

Medicine, 2023, 110: 259-267.

[48]Sunbul M, Gerin F, Durmus E, et al. Neutrophil

to lymphocyte and platelet to lymphocyte ratio in patients

with dipper versus non-dipper hypertension[J]. Clinical and

Experimental Hypertension (New York, N.Y.: 1993), 2014,

36(4): 217-221.

[49]Wu M, Zhou L, Zhu D, et al. Hematological

indices as simple, inexpensive and practical severity markers of

obstructive sleep apnea syndrome: a meta-analysis[J]. Journal

of Thoracic Disease, 2018, 10(12): 6509-6521.

[50]Song YJ, Kwon JH, Kim JY, et al. The plateletto-lymphocyte ratio reflects the severity of obstructive sleep

apnea syndrome and concurrent hypertension[J]. Clinical

Hypertension, 2016, 22: 1.

[51]Koseoglu S, Ozcan KM, Ikinciogullari A, et al.

Relationship Between Neutrophil to Lymphocyte Ratio,

Platelet to Lymphocyte Ratio and Obstructive Sleep Apnea

Syndrome[J]. Advances in Clinical and Experimental

Medicine: Official Organ Wroclaw Medical University, 2015,

24(4): 623-627.


Refbacks

  • 当前没有refback。